What oral hydromorphone dose is equivalent to 20 mg of oxycodone immediate‑release in an adult patient?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 6, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Oral Hydromorphone Equivalent to Oxycodone IR 20mg

Based on the most recent NCCN 2025 guidelines, 20 mg of oral oxycodone immediate-release is equivalent to approximately 5-6 mg of oral hydromorphone.

Conversion Calculation

Using the NCCN 2025 equianalgesic table 1:

  • Oral morphine 30 mg = Oral oxycodone 15-20 mg = Oral hydromorphone 7.5 mg

For 20 mg oxycodone IR:

  • 20 mg oxycodone ≈ 30 mg oral morphine (using the 1:1.5 ratio)
  • 30 mg oral morphine = 7.5 mg oral hydromorphone
  • Therefore: 20 mg oxycodone ≈ 7.5 mg hydromorphone

However, the NCCN table shows a range for oxycodone (15-20 mg), and using the midpoint calculation:

  • If 15 mg oxycodone = 7.5 mg hydromorphone
  • Then 20 mg oxycodone = approximately 10 mg hydromorphone (direct proportion)

The ESMO 2018 guidelines provide a more conservative ratio of oral oxycodone to oral hydromorphone of 1:4 2, which would suggest:

  • 20 mg oxycodone ÷ 4 = 5 mg hydromorphone

Critical Safety Recommendation

When converting between opioids, reduce the calculated equianalgesic dose by 25-50% to account for incomplete cross-tolerance 3. This is essential to prevent overdosing.

Practical Application:

  1. Calculate equianalgesic dose: 20 mg oxycodone = 7.5-10 mg hydromorphone
  2. Reduce by 25-50%: Start with 4-6 mg oral hydromorphone
  3. Provide immediate-release hydromorphone for breakthrough pain (10-15% of total daily dose)
  4. Titrate upward based on pain control and adverse effects

Important Caveats

  • Renal impairment: Hydromorphone metabolites accumulate in renal dysfunction. Use with extreme caution and start at lower doses 1. Consider fentanyl or methadone as safer alternatives in severe renal impairment (CrCl <30 mL/min) 2, 4.

  • Individual variability: The conversion factor between IV and oral hydromorphone ranges from 2.5-5 1, reflecting significant pharmacokinetic variability between patients.

  • Pain control status: If the patient's pain was poorly controlled on oxycodone 20 mg, you may use 100% of the equianalgesic dose (7.5-10 mg) or even increase by 25% 3. If pain was well-controlled, the 25-50% reduction is mandatory.

  • Dose frequency: Hydromorphone IR has a shorter duration of action (2-3 hours) compared to oxycodone IR (3-5 hours) 1, so dosing every 3-4 hours may be needed versus every 4-6 hours for oxycodone.

References

Guideline

adult cancer pain, version 2.2025, nccn clinical practice guidelines in oncology.

Journal of the National Comprehensive Cancer Network : JNCCN, 2025

Guideline

adult cancer pain.

Journal of the National Comprehensive Cancer Network : JNCCN, 2010

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.